KPV – 10mg

Research Applications:

Alpha-MSH Fragment and Inflammation Models

KPV is the C-terminal tripeptide sequence associated with alpha-melanocyte-stimulating hormone research. It is commonly used to examine melanocortin-linked inflammatory signaling without framing the compound as a therapeutic agent [1].
Keratinocyte and epithelial-cell models use KPV to study cytokine response, receptor-independent signaling questions, and barrier-related outputs under controlled inflammatory challenge.

Epithelial and Wound-Response Studies

KPV has been examined in corneal epithelial wound models and nitric-oxide-related repair pathways, making it relevant to assays involving epithelial migration, surface integrity, and inflammation-associated repair endpoints [2].

Neuroinflammation and Apoptosis Models

Experimental traumatic injury models have used alpha-MSH(11-13) to evaluate inflammation and apoptosis readouts, supporting research interest in peptide-fragment signaling across immune and neural contexts [3].

Referenced Citations:

1. KPV / MSH 11-13 and keratinocyte signaling
   Source: PubMed-indexed study on KPV and melanocortin signaling in keratinocyte cells.
2. KPV and corneal epithelial wound models
   Source: PubMed-indexed study examining alpha-MSH(11-13), wound healing, and nitric oxide.
3. Alpha-MSH(11-13) in experimental traumatic brain injury
   Source: PMC full text on inflammation and apoptosis readouts in a mouse model.